Canada: Medical lab chains will combine forces, big bills to come for government
The Competition Bureau has announced that it will not take action to block two of British Columbia’s largest private medical chains from merging. LifeLabs plans to guy BC Biomedical, an acquisition that will mean LifeLab will now bill nearly $200 million a year to the government’s Medical Service Plan for state-funded testing. Despite concerns over the merger, the Medical Services Commission has reportedly approved for LifeLabs to run the former BC Biomedical labs. The parties expect to close the deal in April.
Featured News
DOJ’s Push for Faster Antitrust Investigations Raises Concerns Over Court Delays
Sep 23, 2026 by
CPI
OpenAI Seeks Dismissal of Musk’s AI Antitrust Case, Citing SpaceX SEC Filings
Sep 23, 2026 by
CPI
Google Faces UK Plan to Open Android and Chrome Search to AI Rivals
Sep 23, 2026 by
CPI
Australia Blocks IAG’s $960 Million RAC Insurance Takeover
Sep 23, 2026 by
CPI
Florida Sues Eli Lilly, Novo Nordisk and Pharmacy Benefit Managers Over Insulin Pricing
Sep 23, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton